Background: There is little information available on the features of initial presentation of bronchiectasis and documentation of the onset and progress of symptoms leading up to this. Therefore a study was performed on a large cohort of adult patients presenting to Monash Medical Centre (MMC) to survey the course of their disease up to the time of diagnosis. Objectives: To characterise the onset and presenting clinical features of bronchiectasis in adults. Methods: A cross-sectional study of 103 adults presenting to a tertiary referral hospital with newly diagnosed bronchiectasis. Clinical features of bronchiectasis and results of spirometry, sputum microbiology and radiology were assessed and correlated. Results: Most patients had idiopathic bronchiectasis (74%) and did not have other significant disease. The dominant symptom was chronic productive cough present in 98% of patients with other important symptoms being chronic rhinosinusitis (70%), dyspnoea (62%), and fatigue (74%). Most patients had had a chronic productive cough for over 30 years prior to diagnosis and over 80% of patients had chronic respiratory symptoms from childhood. The dominant finding on physical examination was the presence of crackles which were generally bi-basal. Spirometry showed mild airway obstruction with an average forced expiratory volume in 1 s of the cohort of 76% predicted. Radiologic imaging generally showed multilobar disease (80%).
Introduction
Bronchiectasis is a classic respiratory condition whose clinical profile and presentation has changed significantly since the introduction of antibiotics. A large study performed in 1940 assessed 400 subjects with bronchiectasis. In this study bronchiectasis was associated with a mortality rate of over 30% (in the follow-up period of 2-12 years) with most patients dying before the age of 40. 1 The introduction of antibiotics caused a significant change in the profile of this disease and a retrospective study in 1981 2 found a significantly better outcome with a mortality rate of 13%. Despite the introduction of antibiotics bronchiectasis continues to be an important cause of chronic respiratory disease particularly that with the advent of highresolution computerised tomography (HRCT) the diagnosis is much easier to make. In a study of 110 patients diagnosed as having chronic obstructive pulmonary disease (COPD) by general practitioners, 29% of these subjects were found to have bronchiectasis according to currently accepted CT scanning criteria 3 suggesting that this condition remains relatively common and under diagnosed. Few articles have documented the clinical features of this condition in the past 20 years. In particular, there is very little information available on the features of initial presentation of this condition and documentation of the onset and progress of symptoms leading up to this. Therefore a study was performed on a large cohort of adult patients presenting to Monash Medical Centre (MMC) to survey the course of their disease up to the time of diagnosis.
Methods

Study subjects
A series of 145 adult patients with bronchiectasis was seen at MMC between 1980 and 2001. The diagnosis of bronchiectasis was confirmed by bronchogram or CT scanning after review by a consultant radiologist. There were 103 new diagnoses of bronchiectasis in this cohort (8 from bronchogram and 95 from CT) and these newly diagnosed patients were selected for further analysis.
Methods
All 103 subjects had detailed clinical assessment performed at MMC with a standard proforma to record findings at the time of diagnosis. Patients were asked about the presence and frequency of productive cough, sputum volume (sputum volume was estimated by comparison with a teaspoon (5 ml), tablespoon (15 ml), eggcup (50 ml) and teacup (150 ml)). Details were also obtained about presence of rhinosinusitis, chest pain, haemoptysis in the past 5 years, fatigue/lethargy, frequency of exacerbations (defined by a sustained worsening in their clinical state with at least one of: increase in sputum volume, dyspnoea or fever) and symptoms of dyspnoea using the Medical Research Council (MRC) dyspnoea grade. Subjects were asked about the initial onset and progression of their symptoms, childhood respiratory disease, general health (including questioning about symptoms of autoimmune disease and arthritis) and tobacco consumption. Findings on physical examination were also recorded.
Ethical approval for this project was obtained from the Southern Health Ethics Committee, MMC.
Subjects had spirometry performed for forced expiratory volume in 1 s (FEV 1 ), forced vital capacity (FVC) and bronchodilator (BD) response to inhaled salbutamol at MMC. At least 2 measurements differing by less than 5% or 100 ml from each other had to be produced. The largest volume was used in this analysis. Spirometers were calibrated daily. Patients were also asked to produce a sputum sample which was analysed by microscopy and culture. To assess for predisposing factors for bronchiectasis, all subjects had blood taken for full blood examination, immunoglobulin levels (including subclasses) and alpha1-antitrypsin levels and where clinically indicated further investigations for cystic fibrosis (multiple mutation analysis/sweat testing; done if widespread severe bronchiectasis), ciliary function (done for unexplained infertility), and allergic bronchopulmonary aspergillosis (aspergillus precipitins and skin test reactions; done if there was central bronchiectasis, significant asthma or eosinophilia).
The FEV 1 has been shown to be the most important measure of outcome in COPD. 4 FEV 1 has not been reported in detail in the context of bronchiectasis but it is an important measurement of lung function in this condition. A number of factors have been shown to affect FEV 1 in COPD. 5 In this study, factors that have been shown to affect the outcome of FEV 1 in COPD were looked at in addition to specific factors associated with infection in bronchiectasis. The factors were; volume of sputum, duration of chronic productive cough, frequency of exacerbations, history of smoking, asthma/significant BD effect (defined as415% BD effect after inhaled b agonist), extent of disease on X-ray (bronchogram or CT scanning) and type of bacteria isolated from sputum. All these factors were correlated with the FEV 1 .
Analysis
In all analyses, a Type I error rate (the probability of detecting a statistically significant association when none exists) was set at 5%. Statistical analysis was performed using either Stata SE 8.0 (College Station, Texas) or Prism 2 (California, USA) software. Conventional descriptive measures of the middle (e.g., mean, median) and spread (e.g., standard deviation, interpercentile ranges) were derived for continuous variables, as well as crosstabulations for categorical variables. Comparisons between categorical variables used the Pearson's w 2 statistic (or the Fisher's exact test for small samples). When comparing continuous outcome variables by categorical predictors, the Student's t-test was used (or its non-parametrical equivalent, the Wilcoxon rank sum test). The major outcome of interest, FEV 1 was expressed as percent predicted for age, sex, and height. Multiple linear regression was used to analyse FEV 1 as a continuous variable (from low to high) with other variables. All variables were included in this regression analysis.
Results
Demographic data of the patients are shown in Table 1 . Results are shown for number (n) and percentage of patients. The mean (SD) age of the group was 56 (14) years and the majority of patients were female. Twenty four out of the 103 subjects had a history of smoking which is lower than the expected rate in a group of this age (the expected rate of subjects with a smoking history in Australia is 460% 6 ) (Po0.0001, using the w 2 statistic), and only 7 of the patients were still smoking at the time of review. In patients who had a history of smoking in all but three cases, chronic respiratory symptoms had started before their smoking habit.
The great majority (76 patients) in this cohort were classified as having idiopathic disease. Ten patients were classified as being post-infective (defined as chronic cough and sputum production directly after pneumonia, tuberculosis, whooping cough or measles), 9 had isolated IgG subclass deficiency (2 had low IgG2 levels and 7 had low IgG3 levels) 4 had allergic bronchopulmonary aspergillosis, one patient had Kartagener's syndrome, one patient had Young's syndrome, and two subjects had associated rheumatoid arthritis.
Of the patients, 11 had a previous diagnosis of asthma and 3 had COPD (diagnosed in smokers with non-reversible airway obstruction). Apart from their bronchiectasis patients generally did not have other major illnesses and were all living independently.
All but 2 of the 103 subjects had a history of chronic productive cough ( Table 2 ). The great majority of patients also complained of daily sputum production that was generally mucopurulent and averaged over 30 ml in volume per day. Over half of the patients complained of dyspnoea which was generally mild in severity. Rhinosinusitis (defined as chronic upper respiratory tract symptoms present for more than a year) was a very common symptom and varied from mild intermittent nasal discharge to severe purulent sinusitis. Thirty of the patients gave a history of previous ear nose and throat (ENT) surgery, generally for recurrent sinusitis and 47 of the patients had radiologic abnormalities of the upper airway (ranging from mucosal thickening to severe pansinusitis). Over half the patients described having sputum with flecks of blood at some stage but a smaller number (27 patients) described having frank haemoptysis in the past 5 years which was a cause of considerable concern and generally resulted in immediate medical consultation. A quarter of the patients described having non-ischemic chest pain, which was generally either pleuritic or musculoskeletal in nature. Most patients complained of fatigue/lethargy which interfered with their quality of life, and a number of them felt this was the most dominant symptom.
ARTICLE IN PRESS
Physical examination showed the presence of crackles in most patients which were generally basal in their distribution. Wheeze was the other common examination finding. Only two patients were clubbed.
Over half of patients (55) were initially referred to MMC for the investigation of chronic productive cough ( Table 3 ). The next most common reason for referral was for follow up after an episode of pneumonia in 18 patients.
Spirometry of the group was characterised by mild airway obstruction ( Table 4 ). The FEV 1 of the group was 76% of predicted with a standard deviation of 26%. The FEV 1 /FVC ratio was 67.7 and 41 subjects had an FEV 1 /FVC ratio of o0.7. Twenty-three patients showed significant airway reversibility after inhaled b agonist. The number of patients who had a previous diagnosis of asthma or significant airway reversibility was 29.
Radiological examination showed that most patients (80%) had 2 or more lobes showing evidence of bronchiectasis and the most common pattern was bilateral lower lobe involvement ( Table 4 ). The most commonly involved lobe was the right lower lobe (RLL) which was affected in 69% of patients. The lobe with the least involvement was the right upper lobe (RUL) affected in 13%.
Sputum samples appropriate for microbiological examination were obtained in 94 subjects. The most commonly isolated bacterium was Haemophilus influenzae which was found in 34 subjects ( Table 5 ). Other common bacteria were Moxarella catarrhalis (9 patients), Pseudomonas aeruginosa (7 patients) and Staphylococcus aureus (5 patients). Thirty-six patients had no pathogenic bacteria isolated.
Subjects were asked as some detail about the commencement of chronic respiratory symptoms. The most common symptom was a chronic productive cough which was present in 98% of patients. In over 65% of patients this symptom started in childhood with the most common time of onset being in the first decade of life. Of the group, 19 remembered having pneumonia in childhood, 11 whooping cough and 5 measles. In only 8 of these subjects was there a clear association between these infections and the onset of chronic respiratory symptoms.
Well over 80% of subjects complained of chronic respiratory symptoms in childhood which in addition to chronic cough included wheeze, asthma, and recurrent upper and lower respiratory tract infections that interfered with schooling. Of interest was the observation by over half of patients that the chronic symptoms tended to improve in early adulthood and then often became worse in middle age (over 50 years) when they were often first referred for specialist investigation. Most patients had as a productive cough for 30 years before the diagnosis of bronchiectasis was made. Most patients had been seen by a variety of medical practitioners, the most common diagnoses in the first 10 years of their symptoms being wheezy bronchitis, asthma and COPD. Many patients were not aware of having any specific diagnosis in this time.
A number of variables were correlated with the FEV 1 results (volume of sputum, duration of chronic productive cough, frequency of exacerbations, history of smoking, asthma/significant BD effect, extent of disease on CT scanning and type of bacteria).
Three factors were found to have a significant association with FEV 1 ( Table 6 ). They were; history of smoking, extent of disease on X-ray and P. aeruginosa isolation from sputum.
Discussion
We have assessed 103 patients with adult bronchiectasis to help define the typical presenting features of this condition and to understand the clinical course of the disease leading up to this time.
The reason for initial referral in over half of patients was for chronic productive cough with the next most common reason being after an episode of pneumonia. Generally this cough had been present for over 30 years and particularly as most patients were not smokers the reason why it had taken so long to diagnose bronchiectasis is not clear. It may reflect a combination of factors, principally low awareness on the behalf of the medical profession but also lack of referral/availability for HRCT.
In this study two thirds of subjects were female similar to other recent studies. 14, 17, 18 The reason for this sex difference is not clear. There were also a low number of smokers in this cohort, similar to another article. 18 This may be due to most patients having a productive cough since childhood which became worse on smoking.
Over 70% of the subjects in this cohort had idiopathic disease. Ten of the subjects recalled chronic respiratory symptoms directly commencing after an infectious insult which is lower than in some previous series particularly those from before 1980. 1, 2, [8] [9] [10] [11] [12] The attribution of factors precipitating/preceding bronchiectasis relies generally on long-term retrospective recall and there may previously have been over-ascription to infective causes. 13 There is evidence to suggest that the spectrum of bronchiectasis has changed in the antibiotic era and now this disease which has a large number of possible causes and associations is most commonly idiopathic. 13, 14 The most comprehensive recent assessment of the aetiology of bronchiectasis has been performed by Pasteur et al. 14 This study found that 32% of subjects had an immune defect/associated condition compared with 17% for the current study. Factors that may explain the difference between the 2 studies include a more comprehensive assessment used by Pasteur et al. and the possibility that the 2 groups may differ in their underlying characteristics. Rhinosinusitis which has not always been considered to be a primary feature of bronchiectasis has also been described to be very common in two other studies with a rate of more than 60%. 15, 16 After a chronic cough the most common and troublesome symptom for patients was chronic fatigue/lethargy. Chest pain was present in 19% of subjects at the time of diagnosis; in some cases this was pleuritic and on other occasions was musculoskeletal but commonly the origin of the chest pain was not clear. Clubbing often thought of as being a classic sign in bronchiectasis was found in only two patients and this is consistent with another recent study, 17 possibly reflecting the milder spectrum of disease in the current era.
ARTICLE IN PRESS
Spirometry in most cases showed mild reduction in lung function with airway obstruction being the predominant pattern. Almost 30% of patients had a previous diagnosis of asthma or significant airway reversibility after inhaled b agonist. A previous study showed a BD rate of 40% in a cohort of subjects with bronchiectasis. 7 As in previous studies 14, 18, 19 the most commonly isolated bacteria was Haemophilus influenzae. There was a relatively low isolation of P. aeruginosa possibly reflecting the fact the lung function of most patients was not severely impaired and they had had a low rate of hospitalisation.
Over 80% of the subjects described having some chronic respiratory symptoms in the first 2 decades of life. Interestingly the study of Perry and King in 1940 1 found that over 70% of patients had symptoms that commenced in childhood. Although childhood for most subjects was characterised by regular medical attendances for recurrent respiratory symptoms, in over half of cases subjects were not aware of any specific medical diagnosis. The most common diagnoses made in childhood were asthma and wheezy bronchitis. Many of the patients in this group described their symptoms improving in early adulthood and then becoming worse after the age of 50 possibly reflecting a waning in immune function.
There has been a lack of information assessing factors associated with FEV 1 levels in bronchiectasis. Two factors that are known to be associated with poorer lung function in bronchiectasis are; colonisation with P. aeruginosa, 20 and extensive disease on HRCT. 15 In COPD factors associated with low FEV 1 levels include in addition to smoking; frequency of exacerbations and airway hyper-responsiveness. 5 Whooping cough and pneumonia in childhood have been shown to be associated with a small decrease in adult FEV 1 (70 and 126 ml). 21 In this cohort of subjects with bronchiectasis there was a significant correlation between low FEV 1 and smoking, extent of disease on X-ray and isolation of Pseudomonas in the sputum. In view of the literature these findings were not surprising.
The typical profile of bronchiectasis in this group of patients was of longstanding productive cough, rhinosinusitis and fatigue in non-smokers with crackles on chest auscultation. Such a clinical picture strongly suggests the diagnosis of bronchiectasis and HRCT should be considered in such patients.
